This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Schellekens GA et al. (1998) Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 101: 273–281
Nielen MM et al. (2004) Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 50: 380–386
Kuhn KA et al. (2006) Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J Clin Invest 116: 961–973
Nielen MM et al. (2005) Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis. Ann Rheum Dis 64: 1199–1204
van Dongen H et al. (2006) Probable rheumatoid arthritis methotrexate versus placebo therapy (PROMPT)-study: indications for a window of opportunity in the treatment of patients with undifferentiated arthritis [abstract]. Ann Rheum Dis 65 (Suppl 2): 54
Acknowledgements
The synopsis was written by Jasmine Farsarakis, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
van Laar, J. Antibodies against citrullinated proteins: which test is best?. Nat Rev Rheumatol 2, 652–653 (2006). https://doi.org/10.1038/ncprheum0354
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncprheum0354